Global X Genomics & Biotechnology ETF (GNOM)
GNOM is a passive ETF by Global X tracking the investment results of the Solactive Genomics Index. GNOM launched on Apr 5, 2019 and has a 0.50% expense ratio.
ETF Info
ISIN | US37954Y4347 |
---|---|
CUSIP | 37954Y434 |
Issuer | Global X |
Inception Date | Apr 5, 2019 |
Region | North America (U.S.) |
Category | Health & Biotech Equities |
Index Tracked | Solactive Genomics Index |
Home Page | www.globalxetfs.com |
Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Growth |
Expense Ratio
The Global X Genomics & Biotechnology ETF has a high expense ratio of 0.50%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Global X Genomics & Biotechnology ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Global X Genomics & Biotechnology ETF had a return of -1.11% year-to-date (YTD) and -2.56% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -1.11% | 10.04% |
1 month | -2.31% | 3.53% |
6 months | 11.73% | 22.79% |
1 year | -2.56% | 32.16% |
5 years (annualized) | N/A | 13.15% |
10 years (annualized) | N/A | 10.96% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -6.99% | 11.44% | ||||||||||
2023 | -8.48% | -9.44% | -12.98% | 17.69% | 10.96% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
Global X Genomics & Biotechnology ETF | -0.15 | ||||
S&P 500 | 2.76 |
Dividends
Dividend History
Global X Genomics & Biotechnology ETF granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Dividend | $0.00 | $0.00 | $0.00 | $0.01 | $0.03 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% |
Monthly Dividends
The table displays the monthly dividend distributions for Global X Genomics & Biotechnology ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | $0.00 | $0.00 | ||||||||||
2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 |
2020 | $0.03 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Global X Genomics & Biotechnology ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Global X Genomics & Biotechnology ETF was 68.54%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
The current Global X Genomics & Biotechnology ETF drawdown is 59.00%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-68.54% | Feb 9, 2021 | 685 | Oct 27, 2023 | — | — | — |
-35.36% | Dec 26, 2019 | 57 | Mar 18, 2020 | 42 | May 18, 2020 | 99 |
-21.6% | Apr 11, 2019 | 121 | Oct 2, 2019 | 40 | Nov 27, 2019 | 161 |
-14.38% | Jul 21, 2020 | 35 | Sep 8, 2020 | 21 | Oct 7, 2020 | 56 |
-9.15% | Oct 14, 2020 | 13 | Oct 30, 2020 | 8 | Nov 11, 2020 | 21 |
Volatility
Volatility Chart
The current Global X Genomics & Biotechnology ETF volatility is 6.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.